- Tytuł:
- Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.
- Autorzy:
- Źródło:
- Cancer medicine [Cancer Med] 2019 Aug; Vol. 8 (10), pp. 4678-4687. Date of Electronic Publication: 2019 Jul 05.
- Typ publikacji:
- Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
- MeSH Terms:
-
Cancer Vaccines/*administration & dosage
Endometrial Neoplasms/*prevention & control
Folate Receptors, GPI-Anchored/*chemistry
Neoplasm Recurrence, Local/*prevention & control
Ovarian Neoplasms/*prevention & control
Vaccines, Subunit/*administration & dosage
Aged ; Cancer Vaccines/immunology ; Dose-Response Relationship, Drug ; Endometrial Neoplasms/immunology ; Female ; Folate Receptors, GPI-Anchored/immunology ; Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage ; Granulocyte-Macrophage Colony-Stimulating Factor/immunology ; HLA-A2 Antigen/metabolism ; Humans ; Immunization, Secondary ; Middle Aged ; Neoplasm Recurrence, Local/immunology ; Ovarian Neoplasms/immunology ; Prospective Studies ; Survival Analysis ; Treatment Outcome ; Vaccines, Subunit/immunology
Czasopismo naukowe